US Stock MarketDetailed Quotes

GYRE Gyre Therapeutics

Watchlist

14.900
-0.340-2.23%

Trading Jul 24 11:05 ET

1.27BMarket Cap-14522P/E (TTM)

Gyre Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q1)Mar 31, 2022

(FY)Dec 31, 2021

Total revenue

8.99%27.17M

10.91%113.45M

-0.33%24.93M

14.18%102.29M

25.01M

89.59M

Operating revenue

8.99%27.17M

10.91%113.45M

-0.33%24.93M

14.18%102.29M

--25.01M

--89.59M

Cost of revenue

-12.98%979K

-3.28%4.64M

-6.17%1.13M

19.21%4.79M

1.2M

4.02M

Gross profit

10.03%26.19M

11.61%108.81M

-0.04%23.81M

13.94%97.5M

23.82M

85.57M

Operating expense

5.72%18.12M

1.48%89.6M

8.27%17.14M

59.28%88.29M

15.83M

55.43M

Selling and administrative expenses

9.88%15.94M

5.88%75.82M

5.43%14.51M

48.16%71.61M

--13.76M

--48.33M

-Selling and marketing expense

-1.77%12.54M

12.76%61.16M

12.72%12.77M

21.47%54.24M

--11.33M

--44.65M

-General and administrative expense

95.40%3.4M

-15.59%14.66M

-28.52%1.74M

371.86%17.37M

--2.43M

--3.68M

Research and development costs

-17.19%2.18M

-17.42%13.78M

27.10%2.64M

130.27%16.69M

--2.07M

--7.25M

Other operating expenses

----

---145.28K

Operating profit

21.11%8.07M

108.77%19.21M

-16.52%6.66M

-69.46%9.2M

7.98M

30.13M

Net non-operating interest income expense

78.26%328K

43.80%1.04M

1,444.62%184K

179.28%726K

-13.68K

259.96K

Non-operating interest income

78.26%328K

----

--184K

----

--382.33K

Non-operating interest expense

----

--13.68K

--122.37K

Total other finance cost

----

-43.80%-1.04M

----

---726K

----

Other net income (expense)

807.45%4.08M

-18,705.03%-97.22M

-1,441.34%-577K

34.45%-517K

-37.43K

-788.66K

Gain on sale of security

--4.29M

---9.26M

----

--239.72K

Special income (charges)

----

---86.44M

----

--0

----

-Less:Other special charges

----

--83.1M

----

-Gain on sale of business

----

---2.71M

----

--0

----

-Gain on sale of property,plant,equipment

----

---628K

----

--0

----

Other non- operating income (expenses)

64.30%-206K

-193.62%-1.52M

-1,441.34%-577K

49.73%-517K

---37.43K

---1.03M

Income before tax

99.03%12.48M

-917.73%-76.97M

-20.94%6.27M

-68.21%9.41M

7.93M

29.6M

Income tax

23.95%2.55M

67.03%8.52M

15.40%2.05M

-17.35%5.1M

1.78M

6.17M

Net income

135.59%9.94M

-2,081.46%-85.48M

-31.45%4.22M

-81.59%4.31M

6.15M

23.44M

Net income continuous Operations

135.59%9.94M

-2,081.46%-85.48M

-31.45%4.22M

-81.59%4.31M

--6.15M

--23.44M

Minority interest income

21.79%2.4M

270.43%7.45M

1.97M

2.01M

Net income attributable to the parent company

235.65%7.53M

-4,137.05%-92.93M

-63.52%2.24M

-90.18%2.3M

6.15M

23.44M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

235.65%7.53M

-4,137.05%-92.93M

-63.52%2.24M

-90.18%2.3M

6.15M

23.44M

Basic earnings per share

207.16%0.09

-4,790.77%-1.41

-63.52%0.0293

-90.18%0.0301

0.0803

0.306

Diluted earnings per share

2.39%0.03

-4,790.77%-1.41

-63.52%0.0293

-90.18%0.0301

0.0803

0.306

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q1)Mar 31, 2022	(FY)Dec 31, 2021
Total revenue	8.99%27.17M	10.91%113.45M	-0.33%24.93M	14.18%102.29M	25.01M	89.59M
Operating revenue	8.99%27.17M	10.91%113.45M	-0.33%24.93M	14.18%102.29M	--25.01M	--89.59M
Cost of revenue	-12.98%979K	-3.28%4.64M	-6.17%1.13M	19.21%4.79M	1.2M	4.02M
Gross profit	10.03%26.19M	11.61%108.81M	-0.04%23.81M	13.94%97.5M	23.82M	85.57M
Operating expense	5.72%18.12M	1.48%89.6M	8.27%17.14M	59.28%88.29M	15.83M	55.43M
Selling and administrative expenses	9.88%15.94M	5.88%75.82M	5.43%14.51M	48.16%71.61M	--13.76M	--48.33M
-Selling and marketing expense	-1.77%12.54M	12.76%61.16M	12.72%12.77M	21.47%54.24M	--11.33M	--44.65M
-General and administrative expense	95.40%3.4M	-15.59%14.66M	-28.52%1.74M	371.86%17.37M	--2.43M	--3.68M
Research and development costs	-17.19%2.18M	-17.42%13.78M	27.10%2.64M	130.27%16.69M	--2.07M	--7.25M
Other operating expenses	----	----	----	----	----	---145.28K
Operating profit	21.11%8.07M	108.77%19.21M	-16.52%6.66M	-69.46%9.2M	7.98M	30.13M
Net non-operating interest income expense	78.26%328K	43.80%1.04M	1,444.62%184K	179.28%726K	-13.68K	259.96K
Non-operating interest income	78.26%328K	----	--184K	----	----	--382.33K
Non-operating interest expense	----	----	----	----	--13.68K	--122.37K
Total other finance cost	----	-43.80%-1.04M	----	---726K	----	----
Other net income (expense)	807.45%4.08M	-18,705.03%-97.22M	-1,441.34%-577K	34.45%-517K	-37.43K	-788.66K
Gain on sale of security	--4.29M	---9.26M	----	----	----	--239.72K
Special income (charges)	----	---86.44M	----	--0	----	----
-Less:Other special charges	----	--83.1M	----	----	----	----
-Gain on sale of business	----	---2.71M	----	--0	----	----
-Gain on sale of property,plant,equipment	----	---628K	----	--0	----	----
Other non- operating income (expenses)	64.30%-206K	-193.62%-1.52M	-1,441.34%-577K	49.73%-517K	---37.43K	---1.03M
Income before tax	99.03%12.48M	-917.73%-76.97M	-20.94%6.27M	-68.21%9.41M	7.93M	29.6M
Income tax	23.95%2.55M	67.03%8.52M	15.40%2.05M	-17.35%5.1M	1.78M	6.17M
Net income	135.59%9.94M	-2,081.46%-85.48M	-31.45%4.22M	-81.59%4.31M	6.15M	23.44M
Net income continuous Operations	135.59%9.94M	-2,081.46%-85.48M	-31.45%4.22M	-81.59%4.31M	--6.15M	--23.44M
Minority interest income	21.79%2.4M	270.43%7.45M	1.97M	2.01M
Net income attributable to the parent company	235.65%7.53M	-4,137.05%-92.93M	-63.52%2.24M	-90.18%2.3M	6.15M	23.44M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	235.65%7.53M	-4,137.05%-92.93M	-63.52%2.24M	-90.18%2.3M	6.15M	23.44M
Basic earnings per share	207.16%0.09	-4,790.77%-1.41	-63.52%0.0293	-90.18%0.0301	0.0803	0.306
Diluted earnings per share	2.39%0.03	-4,790.77%-1.41	-63.52%0.0293	-90.18%0.0301	0.0803	0.306
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall